Skip to main content

Table 2 Patients’ characteristics

From: A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types

Patient number Age Sex CEA (ng/ml) Location Tumor size on CT (mm) Histological type TNM classification EGFR mutation
2 55 M 3.9 Rt.S1 11 pseudo-Normala AIS T1aN0M0 Unkown
4 59 W 8.1 Lt.S1 + 2 15 pseudo-Normala LPIA T1bN0M0 Unkown
9 55 W 5.3 Rt.S4 37 pseudo-Normala LPIA T1bN0M0 Unkown
1 63 W 1.9 Rt.S2 15 Adenocarcinoma AIS T1aN0M0 Unkown
2 55 M 3.9 Rt.S1 11 Adenocarcinoma AIS T1aN0M0 Unkown
3 56 W 2 Lt.S8 10 Adenocarcinoma AIS T1aN0M0 Unkown
4 59 W 8.1 Lt.S3 28 Adenocarcinoma MIA T1bN0M0 Unkown
5 73 W 5.4 Rt.S5 25 Adenocarcinoma MIA T1bN0M0 Unkown
6 74 W 1.5 Lt.S3 25 Adenocarcinoma MIA T1bN0M0 L858R
7 78 W 1.5 Rt.S3 37 Adenocarcinoma LPIA T2aN0M0 L858R
8 72 W 0.6 Rt.S1 51 Adenocarcinoma LPIA T2aN0M0 Unkown
9 55 W 5.3 Rt.S4 37 Adenocarcinoma LPIA T1bN0M0 Unkown
  1. alesions judged pathologically as non-cancerous regions adjacent to tumors